Bio-Rad Laboratories (BIO-B) Interest Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Interest Expenses data on file, last reported at $12.3 million in Q1 2026.

• Interest Expenses for Q1 2026 came in at $12.3 million, up 2.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.3 million (up 1.44% YoY), and the FY2025 annual result was $49.0 million, changed 0.2% from the prior year.
• Interest Expenses improved to $12.3 million in Q1 2026 per BIO-B's latest filing, from $12.1 million in the prior quarter.
• Over five years, Interest Expenses peaked at $12.6 million in Q2 2025 and troughed at $4.0 million in Q1 2022.
• A 5-year average of $11.6 million and a median of $12.3 million in 2024 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2022 and 2025: Interest Expenses soared 3105.77% in 2022, then decreased 2.44% in 2025.
• A 5-year view of Interest Expenses shows it stood at $11.7 million in 2022, then grew by 5.6% to $12.3 million in 2023, then declined by 0.99% to $12.2 million in 2024, then slipped by 0.82% to $12.1 million in 2025, then gained by 1.65% to $12.3 million in 2026.
• Business Quant data shows BIO-B's Interest Expenses at $12.3 million in Q1 2026, $12.1 million in Q4 2025, and $12.3 million in Q3 2025.